Estimating the Potential Effects of a Vaccine Program Against an Emerging Influenza Pandemic—United States
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estimating the Potential Effects of a Vaccine Program Against an Emerging Influenza Pandemic—United States
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 60, Issue suppl_1, Pages S20-S29
Publisher
Oxford University Press (OUP)
Online
2015-04-15
DOI
10.1093/cid/ciu1175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Standardizing Scenarios to Assess the Need to Respond to an Influenza Pandemic
- (2015) Martin I. Meltzer et al. CLINICAL INFECTIOUS DISEASES
- Vaccinations Administered During Off-Clinic Hours at a National Community Pharmacy: Implications for Increasing Patient Access and Convenience
- (2013) J. A. Goad et al. ANNALS OF FAMILY MEDICINE
- Population-Level Antibody Estimates to Novel Influenza A/H7N9
- (2013) Maciej F. Boni et al. JOURNAL OF INFECTIOUS DISEASES
- Receptor binding by an H7N9 influenza virus from humans
- (2013) Xiaoli Xiong et al. NATURE
- Biological features of novel avian influenza A (H7N9) virus
- (2013) Jianfang Zhou et al. NATURE
- Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
- (2013) Hai-Nv Gao et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
- (2013) Louis F. Fries et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
- (2013) Rongbao Gao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low immunogenicity predicted for emerging avian-origin H7N9
- (2013) Anne S. De Groot et al. Human Vaccines & Immunotherapeutics
- A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
- (2012) Robert B. Couch et al. PLoS One
- Virus-like particle (VLP)-based vaccines for pandemic influenza
- (2012) Constantino López-Macías Human Vaccines & Immunotherapeutics
- Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations
- (2011) Vic Veguilla et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial
- (2011) John J. Treanor et al. VACCINE
- H5N1 Avian Influenza: Preventive and Therapeutic Strategies Against a Pandemic
- (2010) Suryaprakash Sambhara et al. Annual Review of Medicine
- Surveillance for Influenza during the 2009 Influenza A (H1N1) Pandemic-United States, April 2009-March 2010
- (2010) L. Brammer et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology of 2009 Pandemic Influenza A (H1N1) in the United States
- (2010) Michael A. Jhung et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study
- (2010) Joan Puig-Barberà et al. VACCINE
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older
- (2009) Ann R. Falsey et al. JOURNAL OF INFECTIOUS DISEASES
- A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
- (2009) Rebecca J. Cox et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started